NORTH BERGEN, N.J., Aug. 8, 2025 /PRNewswire/ -- DermaRite Industries, LLC is voluntarily recalling individual lots of products in the table below due to...
Bidding War Expected for Legendary Firearm as Eyes Turn to Caracas
BEDFORD, Texas, Aug. 8, 2025 /PRNewswire/ -- An ornate presentation flintlock owned by South...
CHICAGO, Aug. 8, 2025 /PRNewswire/ -- ShipBob, a leading global supply chain and fulfillment platform for SMB and mid-market omnichannel merchants, announced its De...
Employees also assemble over 1,000 care items as part of HGE Cares community impact initiative
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Home Genius Exteriors (HGE)...
Ninth Circuit Victory on Hold as California Seeks En Banc Rehearing
BOCA RATON, Fla., Aug. 8, 2025 /PRNewswire/ -- In a major Second Amendment ruling,...
TAIPEI, Aug. 8, 2025 /PRNewswire/ -- WCC Biomedical, a leader in novel drug delivery systems, will attend the upcoming NACDS Total Store Expo (TSE), where...
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit – captioned Ho v. Rocket Pharmaceuticals, Inc., No. 25-cv-10049 (D.N.J.) – seeks to represent purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities and charges Rocket Pharmaceuticals and one of Rocket Pharmaceuticals’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed case is captioned Yankov v. Rocket Pharmaceuticals, Inc., No. 25-cv-13532 (D.N.J.).
ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.
Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
Stibnite Gold Project Listed as a White House Transparency Project
Perpetua Anticipates 550+ Direct Jobs in Idaho during operations
Perpetua Announces Stibnite Launch Scholarship with...